NEW YORK (GenomeWeb News) – Bioinformatics firm GenoSplice Technology and Institut Curie's Curie-Cancer today said they are collaborating in the area of cancer genomics.

GenoSplice will have access to several Curie-Cancer technology platforms and be included in Institut Curie research programs. In addition to contributing to the development of new oncology products, the collaboration will result in a better understanding of complex diseases through genome mapping, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.